Coherus BioSciences Inc News - CHRS | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Coherus BioSciences Inc (CHRS)
Coherus BioSciences Inc (CHRS) News

Coherus BioSciences Inc (CHRS)

1.04

0.02

(1.96%)

Closed September 24 4:00PM

Delayed by 15 minutes

1.0395

-0.0005

(-0.05%)

After Hours: 7:59PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update

– Net revenue of $65.0 million in Q2 2024 – – CHS-114 Phase 1 Study Recruitment Continues into Expansion...

Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024

REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS...

Form 4 - Statement of changes in beneficial ownership of securities

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction

REDWOOD CITY, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
Next

Monksdream

Monksdream 1 week ago

CHRS new 52 week low

Monksdream

Monksdream 2 months ago

Monksdream

Monksdream 2 months ago

glenn1919

glenn1919 2 months ago

CHRS...................https://stockcharts.com/h-sc/ui?s=CHRS&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 5 months ago

frans

frans 7 months ago

short interest about 28.000.000 milj.up 7% today

Mile High Marauder

Mile High Marauder 7 months ago

Here is short interest link

https://www.nasdaq.com/market-activity/stocks/chrs/short-interest

frans

frans 7 months ago

you know how many shorts we have here to cover ????
my last buy was 2.08

Mile High Marauder

Mile High Marauder 7 months ago

I think selling these non core assets, with the probability of selling more has greatly diminished the need to raise money and has put some pressure on the shorts to cover some of this massive short. IMO

frans

frans 8 months ago

Coherus’ oncology assets include the UDENYCA® (pegfilgrastim-cbqv) franchise, with three FDA-approved presentations; LOQTORZI™ (toripalimab-tpzi), an FDA-approved, next-generation PD-1 inhibitor; and an immuno-oncology pipeline of next-generation tumor microenvironment oncology drug candidates.

Closing is anticipated in from jan 22

Mile High Marauder

Mile High Marauder 8 months ago

What fda news are u looking for?

frans

frans 8 months ago

up 14 % FDA news is coming

frans

frans 8 months ago

MM's we see an small cover now ? or company sell more ??,

Mile High Marauder

Mile High Marauder 8 months ago

27million share short. I wonder what the true valuation of the company is? I sure hope the shorts have to cover some day. I can’t say I’ve Seen a short this large on a listed stock. Implosion or explosion ,I guess only time will tell.

moonurneighbor

moonurneighbor 8 months ago

I think they are preparing for a sale

Awl416

Awl416 8 months ago

Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium

frans

frans 8 months ago

up from here now for the 1e FDA news

frans

frans 8 months ago

company dump big big here

frans

frans 8 months ago

have we an new company dump now ???????

frans

frans 9 months ago

now up from here and wait on FDA news (should be good)

glenn1919

glenn1919 9 months ago

CHRS...........................https://stockcharts.com/h-sc/ui?s=CHRS&p=W&b=5&g=0&id=p86431144783

tbonaces80

tbonaces80 9 months ago

Cup and handle formed

tbonaces80

tbonaces80 9 months ago

We will test HOD. HH and HL’s

Mile High Marauder

Mile High Marauder 9 months ago

I find it hard to believe they’re going to dilute this company by 40% at this point Or at this price but you never know.

Sierra20

Sierra20 9 months ago

eneels01

eneels01 9 months ago

Company needs to issue 40M shares at $2/sh. This would raise $80M, which would be enough to get through mid 2025…

Mile High Marauder

Mile High Marauder 10 months ago

21 million share short!! What is going on!

Monksdream

Monksdream 10 months ago

CHRS new 52 week low

frans

frans 10 months ago

about end dec.23 finish tests 400 peoples - FDA commercialization about june 24 if no problems

eneels01

eneels01 10 months ago

Wow, instead of having a chance to go to $9, this stock has more of a chance to hit $1 by 2024. Oh well, I will just keep averaging down and sell when it eventually hits $5 again. Unfortunately that might not take place until 2025 or even 2026…

frans

frans 10 months ago

I selled and come back begin jan 24 after finish test 400 peoples about end dec. 23

Mile High Marauder

Mile High Marauder 10 months ago

Any idea who has this much stock to sell? I don’t see very many 5% holders.

frans

frans 11 months ago

what is going on here ??

TimeFades

TimeFades 11 months ago

Monksdream

Monksdream 11 months ago

TimeFades

TimeFades 11 months ago

Monksdream

Monksdream 11 months ago

Few and far between in the biomed sector this year

frans

frans 11 months ago

slowly up from here

Monksdream

Monksdream 11 months ago

CHRS morning rally

TimeFades

TimeFades 11 months ago

TimeFades

TimeFades 11 months ago

Sold out first thing at 4 watching

TheFinalCD

TheFinalCD 11 months ago

Mile High Marauder

Mile High Marauder 11 months ago

Didn’t mean dog

Mile High Marauder

Mile High Marauder 11 months ago

This dog has an 18 million shares short in it, somebody’s been betting big against it or think they know something we don’t

TIMGZ

TIMGZ 11 months ago

INSTITUTIONS ARE BUYING UP ALL AND EVERY POTENTIALS******STILL, IT WILL EVENTUALLY DRIZZLE DOWN

TheFinalCD

TheFinalCD 11 months ago

I bought the dip, but the float is practically owned by Institutions

thats the problem I see here

80% https://finviz.com/quote.ashx?t=CHRS&p=d

TIMGZ

TIMGZ 11 months ago

CHRS****OPPORTUNITY TO BUY MORE OR STILL WAIT FOR DIRECTION??????????

TheFinalCD

TheFinalCD 11 months ago

3.10 GOING WRONG WAY

MAYBE THE NEWS ISNT AS BIG AS HOPED??

TheFinalCD

TheFinalCD 11 months ago

LOQTORZI $CHRS

What is nasopharyngeal carcinoma? Nasopharyngeal carcinoma (also known as NPC) is a rare tumor of the head and neck which originates in the nasopharynx. The nasopharynx is located at the very back of the nose near the Eustachian tubes (Figure).

good part is

LOQTORZI is the first and only FDA-approved treatment for NPC

TimeFades

TimeFades 11 months ago

Coherus BioSciences

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions